The 5-Ws of immunotherapy in head and neck cancer

This publication has 123 references indexed in Scilit:

• Causes, consequences, and reversal of immune system aging
  Journal of Clinical Investigation, 2013
• PD-1–Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer
  Cancer Research, 2013
• Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8⁺T-cell immunity
  OncoImmunology, 2012
• Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma
  BMC Microbiology, 2012
• PD-1 Blockage Reverses Immune Dysfunction and Hepatitis B Viral Persistence in a Mouse Animal Model
  PLOS ONE, 2012
• Tumor Infiltrating CD8+ and Foxp3+ Lymphocytes Correlate to Clinical Outcome and Human Papillomavirus (HPV) Status in Tonsillar Cancer
  PLOS ONE, 2012
• Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients
  Journal of Experimental Medicine, 2010
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
  Radiotherapy and Oncology, 2009
• Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
  New England Journal of Medicine, 2008
• Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?
  Immunology Today, 1999